The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
Winlevi is authorized in EU for the treatment of acne vulgaris
The company’s virgin PET chips plant in Egypt, commissioned in Q4 FY25, achieved 74.8 per cent capacity utilization in its first full quarter. In India, the Panipat facility operated at 96.6 per cent utilization
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
Subscribe To Our Newsletter & Stay Updated
